Shane O'Brien, Henrik Hammarén, Bryan Strouse, Mary Antonysamy, Dwaipayan Patnaik, Hoang Tran, Anthony Mazurek, Michael McCabe. "Momelotinib's unique polypharmacology supports indication expansion beyond myelofibrosis." Blood, 2025. doi:10.1182/blood-2025-7853